MicroRNAs in myeloproliferative neoplasms

British Journal of Haematology

Volumn 161, Issue 4, 2013, Pages 471-483

  Zhan, Huichun ^a,b   Cardozo, Christopher ^a,c   Raza, Azra ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Essential thrombocythaemia; MicroRNA; Myelofibrosis; Myeloproliferative neoplasm; Polycythaemia vera

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; JANUS KINASE 2; MICRORNA; MICRORNA 125; MICRORNA 126; MICRORNA 145; MICRORNA 146A; MICRORNA 150; MICRORNA 155; MICRORNA 15A; MICRORNA 17HG; MICRORNA 181; MICRORNA 196B; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 24; MICRORNA 29; MICRORNA 34; MICRORNA 451; PARVOVIRUS VECTOR; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE;

BIOGENESIS; CANCER GENE THERAPY; CANCER GROWTH; DRUG EFFICACY; DRUG POTENCY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HEMATOPOIESIS; HUMAN; JANUS KINASE 2 GENE; LEUKEMOGENESIS; LOSS OF FUNCTION MUTATION; MOLECULAR CLONING; MOLECULAR PATHOLOGY; MYELOFIBROSIS; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR GENE; UPREGULATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIESIS; HUMANS; MICRORNAS; MYELOPROLIFERATIVE DISORDERS;

EID: 84876812483     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12276     Document Type: Review

References (136)

1. Adamson, J.W., Fialkow, P.J., Murphy, S., Prchal, J.F. & Steinmann, L. (1976) Polycythemia vera: stem-cell and probable clonal origin of the disease. New England Journal of Medicine, 295, 913-916.
2. Ambros, V. (2008) The evolution of our thinking about microRNAs. Nature Medicine, 14, 1036-1040.
3. Anand, S., Stedham, F., Beer, P., Gudgin, E., Ortmann, C.A., Bench, A., Erber, W., Green, A.R. & Huntly, B.J. (2011) Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms. Blood, 118, 177-181.
4. Baek, D., Villen, J., Shin, C., Camargo, F.D., Gygi, S.P. & Bartel, D.P. (2008) The impact of microRNAs on protein output. Nature, 455, 64-71.
5. Barroga, C.F., Pham, H. & Kaushansky, K. (2008) Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Experimental Hematology, 36, 1585-1592.
6. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
7. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
8. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. & Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054-1061.
9. Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature, 409, 363-366.
10. Boldin, M.P., Taganov, K.D., Rao, D.S., Yang, L., Zhao, J.L., Kalwani, M., Garcia-Flores, Y., Luong, M., Devrekanli, A., Xu, J., Sun, G., Tay, J., Linsley, P.S. & Baltimore, D. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. Journal of Experimental Medicine, 208, 1189-1201.
11. Bortoluzzi, S., Bisognin, A., Biasiolo, M., Guglielmelli, P., Biamonte, F., Norfo, R., Manfredini, R., Vannucchi, A.M. & Investigators, A. (2012) Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells. Blood, 119, e120-e130.
12. Bousquet, M., Harris, M.H., Zhou, B. & Lodish, H.F. (2010) MicroRNA miR-125b causes leukemia. Proceedings of the National Academy of Sciences of the USA, 107, 21558-21563.
13. Bruchova, H., Yoon, D., Agarwal, A.M., Mendell, J. & Prchal, J.T. (2007) Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Experimental Hematology, 35, 1657-1667.
14. Bruchova, H., Merkerova, M. & Prchal, J.T. (2008) Aberrant expression of microRNA in polycythemia vera. Haematologica, 93, 1009-1016.
15. Bruchova-Votavova, H., Yoon, D. & Prchal, J.T. (2010) miR-451 enhances erythroid differentiation in K562 cells. Leukaemia & Lymphoma, 51, 686-693.
16. Byon, J.C. & Papayannopoulou, T. (2012) MicroRNAs: Allies or foes in erythropoiesis? Journal of Cellular Physiology, 227, 7-13.
17. Cai, X., Hagedorn, C.H. & Cullen, B.R. (2004) Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA, 10, 1957-1966.
18. Calin, G.A., Liu, C.G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C.D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., Dell'Aquila, M.L., Alder, H., Rassenti, L., Kipps, T.J., Bullrich, F., Negrini, M. & Croce, C.M. (2004a) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the USA, 101, 11755-11760.
19. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. & Croce, C.M. (2004b) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the USA, 101, 2999-3004.
20. Campbell, P.J., Scott, L.M., Buck, G., Wheatley, K., East, C.L., Marsden, J.T., Duffy, A., Boyd, E.M., Bench, A.J., Scott, M.A., Vassiliou, G.S., Milligan, D.W., Smith, S.R., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Harrison, C.N. & Green, A.R. (2005) Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet, 366, 1945-1953.
21. Chang, T.C., Yu, D., Lee, Y.S., Wentzel, E.A., Arking, D.E., West, K.M., Dang, C.V., Thomas-Tikhonenko, A. & Mendell, J.T. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics, 40, 43-50.
22. Cheloufi, S., Dos Santos, C.O., Chong, M.M. & Hannon, G.J. (2010) A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature, 465, 584-589.
23. Chen, C.Z., Li, L., Lodish, H.F. & Bartel, D.P. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-86.
24. Chen, E., Beer, P.A., Godfrey, A.L., Ortmann, C.A., Li, J., Costa-Pereira, A.P., Ingle, C.E., Dermitzakis, E.T., Campbell, P.J. & Green, A.R. (2010) Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. Cancer Cell, 18, 524-535.
25. Chim, C.S., Wan, T.S., Wong, K.Y., Fung, T.K., Drexler, H.G. & Wong, K.F. (2011) Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. Journal of Translational Medicine, 9, 197.
26. Cifuentes, D., Xue, H., Taylor, D.W., Patnode, H., Mishima, Y., Cheloufi, S., Ma, E., Mane, S., Hannon, G.J., Lawson, N.D., Wolfe, S.A. & Giraldez, A.J. (2010) A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science, 328, 1694-1698.
27. Denli, A.M., Tops, B.B., Plasterk, R.H., Ketting, R.F. & Hannon, G.J. (2004) Processing of primary microRNAs by the Microprocessor complex. Nature, 432, 231-235.
28. Dore, L.C., Amigo, J.D., Dos Santos, C.O., Zhang, Z., Gai, X., Tobias, J.W., Yu, D., Klein, A.M., Dorman, C., Wu, W., Hardison, R.C., Paw, B.H. & Weiss, M.J. (2008) A GATA-1-regulated microRNA locus essential for erythropoiesis. Proceedings of the National Academy of Sciences of the USA, 105, 3333-3338.
29. Ebert, P.J., Jiang, S., Xie, J., Li, Q.J. & Davis, M.M. (2009) An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nature Immunology, 10, 1162-1169.
30. Edelstein, L.C. & Bray, P.F. (2011) MicroRNAs in platelet production and activation. Blood, 117, 5289-5296.
31. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M.L., Nervi, C. & Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell, 123, 819-831.
32. Felli, N., Fontana, L., Pelosi, E., Botta, R., Bonci, D., Facchiano, F., Liuzzi, F., Lulli, V., Morsilli, O., Santoro, S., Valtieri, M., Calin, G.A., Liu, C.G., Sorrentino, A., Croce, C.M. & Peschle, C. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proceedings of the National Academy of Sciences of the USA, 102, 18081-18086.
33. Felli, N., Pedini, F., Romania, P., Biffoni, M., Morsilli, O., Castelli, G., Santoro, S., Chicarella, S., Sorrentino, A., Peschle, C. & Marziali, G. (2009) MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica, 94, 479-486.
34. Fontana, L., Pelosi, E., Greco, P., Racanicchi, S., Testa, U., Liuzzi, F., Croce, C.M., Brunetti, E., Grignani, F. & Peschle, C. (2007) MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nature Cell Biology, 9, 775-787.
35. Girardot, M., Pecquet, C., Boukour, S., Knoops, L., Ferrant, A., Vainchenker, W., Giraudier, S. & Constantinescu, S.N. (2010) miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood, 116, 437-445.
36. Godfrey, A.L., Chen, E., Pagano, F., Ortmann, C.A., Silber, Y., Bellosillo, B., Guglielmelli, P., Harrison, C.N., Reilly, J.T., Stegelmann, F., Bijou, F., Lippert, E., McMullin, M.F., Boiron, J.M., Dohner, K., Vannucchi, A.M., Besses, C., Campbell, P.J. & Green, A.R. (2012) JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone. Blood, 120, 2704-2707.
37. Gregory, R.I., Yan, K.P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N. & Shiekhattar, R. (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature, 432, 235-240.
38. Guglielmelli, P., Tozzi, L., Pancrazzi, A., Bogani, C., Antonioli, E., Ponziani, V., Poli, G., Zini, R., Ferrari, S., Manfredini, R., Bosi, A. & Vannucchi, A.M. (2007) MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Experimental Hematology, 35, 1708-1718.
39. Guglielmelli, P.L., Tagliarico, E., Zini, R., Norfo, R., Bosi, A., Vaddi, K., Burn, T., Contel, N., Verstovsek, S., Manfredini, R. & Vannucchi, A.M. (2011a) Treatment with ruxolitinib (INCB018424) induced changes of microrna expression in granulocytes of patients with polycythemia vera and essential thrombocythemia. Blood (ASH Annual Meeting Abstracts), 118, 3852.
40. Guglielmelli, P., Tozzi, L., Bogani, C., Iacobucci, I., Ponziani, V., Martinelli, G., Bosi, A. & Vannucchi, A.M. (2011b) Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera. Blood, 117, 6923-6927.
41. Guo, H., Ingolia, N.T., Weissman, J.S. & Bartel, D.P. (2010a) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466, 835-840.
42. Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J.Y., Fox, M.C., Purton, L.E., Fleming, H.H., Cobb, B., Merkenschlager, M., Golub, T.R. & Scadden, D.T. (2010b) MicroRNA miR-125a controls hematopoietic stem cell number. Proceedings of the National Academy of Sciences of the USA, 107, 14229-14234.
43. Guo, S., Bai, H., Megyola, C.M., Halene, S., Krause, D.S., Scadden, D.T. & Lu, J. (2012) Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms. Proceedings of the National Academy of Sciences of the USA, 109, 16636-16641.
44. Han, Y.C., Park, C.Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J.B., Liu, M., Zou, Y., Weissman, I.L. & Gu, H. (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. Journal of Experimental Medicine, 207, 475-489.
45. Harrison, C., Kiladjian, J.J., Al-Ali, H.K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D.S., Levy, R., Knoops, L., Cervantes, F., Vannucchi, A.M., Barbui, T. & Barosi, G. (2012) JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. New England Journal of Medicine, 366, 787-798.
46. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J. & Hammond, S.M. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
47. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A.L., Linsley, P.S., Chen, C., Lowe, S.W., Cleary, M.A. & Hannon, G.J. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
48. Howlader, N., Noone, A.M., Krapcho, M., Neyman, N., Aminou, R., Altekruse, S.F., Kosary, C.L., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M.P., Lewis, D.R., Chen, H.S., Feuer, E.J. & Cronin, K.A. (2011) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda, MD.
49. Huang, X., Gschweng, E., Van Handel, B., Cheng, D., Mikkola, H.K. & Witte, O.N. (2011) Regulated expression of microRNAs-126/126* inhibits erythropoiesis from human embryonic stem cells. Blood, 117, 2157-2165.
50. Hussein, K., Dralle, W., Theophile, K., Kreipe, H. & Bock, O. (2009a) Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Annals of Hematology, 88, 325-332.
51. Hussein, K., Theophile, K., Dralle, W., Wiese, B., Kreipe, H. & Bock, O. (2009b) MicroRNA expression profiling of megakaryocytes in primary myelofibrosis and essential thrombocythemia. Platelets, 20, 391-400.
52. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. & Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144-1148.
53. Johnnidis, J.B., Harris, M.H., Wheeler, R.T., Stehling-Sun, S., Lam, M.H., Kirak, O., Brummelkamp, T.R., Fleming, M.D. & Camargo, F.D. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature, 451, 1125-1129.
54. Johnson, S.M., Lin, S.Y. & Slack, F.J. (2003) The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Developmental Biology, 259, 364-379.
55. Jones, A.V., Kreil, S., Zoi, K., Waghorn, K., Curtis, C., Zhang, L., Score, J., Seear, R., Chase, A.J., Grand, F.H., White, H., Zoi, C., Loukopoulos, D., Terpos, E., Vervessou, E.C., Schultheis, B., Emig, M., Ernst, T., Lengfelder, E., Hehlmann, R., Hochhaus, A., Oscier, D., Silver, R.T., Reiter, A. & Cross, N.C. (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 106, 2162-2168.
56. Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A.G. & Nishikura, K. (2007) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science, 315, 1137-1140.
57. Kim, V.N. (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology, 6, 376-385.
58. Koralov, S.B., Muljo, S.A., Galler, G.R., Krek, A., Chakraborty, T., Kanellopoulou, C., Jensen, K., Cobb, B.S., Merkenschlager, M., Rajewsky, N. & Rajewsky, K. (2008) Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell, 132, 860-874.
59. Kota, J., Chivukula, R.R., O'Donnell, K.A., Wentzel, E.A., Montgomery, C.L., Hwang, H.W., Chang, T.C., Vivekanandan, P., Torbenson, M., Clark, K.R., Mendell, J.R. & Mendell, J.T. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 137, 1005-1017.
60. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. & Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779-1790.
61. Kumar, M.S., Narla, A., Nonami, A., Mullally, A., Dimitrova, N., Ball, B., McAuley, J.R., Poveromo, L., Kutok, J.L., Galili, N., Raza, A., Attar, E., Gilliland, D.G., Jacks, T. & Ebert, B.L. (2011) Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood, 118, 4666-4673.
62. Labbaye, C., Spinello, I., Quaranta, M.T., Pelosi, E., Pasquini, L., Petrucci, E., Biffoni, M., Nuzzolo, E.R., Billi, M., Foa, R., Brunetti, E., Grignani, F., Testa, U. & Peschle, C. (2008) A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nature Cell Biology, 10, 788-801.
63. Lambert, J.R., Gale, R.E. & Linch, D.C. (2009) The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia. British Journal of Haematology, 145, 128-130.
64. Landthaler, M., Yalcin, A. & Tuschl, T. (2004) The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Current Biology, 14, 2162-2167.
65. Le, M.T., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H.F. & Lim, B. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes & Development, 23, 862-876.
66. Lee, Y., Jeon, K., Lee, J.T., Kim, S. & Kim, V.N. (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO Journal, 21, 4663-4670.
67. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S. & Kim, V.N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature, 425, 415-419.
68. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H. & Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal, 23, 4051-4060.
69. Leung, A.K. & Sharp, P.A. (2010) MicroRNA functions in stress responses. Molecular Cell, 40, 205-215.
70. Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D'Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J. & Gilliland, D.G. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387-397.
71. Li, Q.J., Chau, J., Ebert, P.J., Sylvester, G., Min, H., Liu, G., Braich, R., Manoharan, M., Soutschek, J., Skare, P., Klein, L.O., Davis, M.M. & Chen, C.Z. (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell, 129, 147-161.
72. Li, J., Spensberger, D., Ahn, J.S., Anand, S., Beer, P.A., Ghevaert, C., Chen, E., Forrai, A., Scott, L.M., Ferreira, R., Campbell, P.J., Watson, S.P., Liu, P., Erber, W.N., Huntly, B.J., Ottersbach, K. & Green, A.R. (2010) JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood, 116, 1528-1538.
73. Li, H., Zhao, H., Wang, D. & Yang, R. (2011) microRNA regulation in megakaryocytopoiesis. British Journal of Haematology, 155, 298-307.
74. Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Linsley, P.S. & Johnson, J.M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.
75. Lin, X., Rice, K.L., Buzzai, M., Hexner, E., Costa, F.F., Kilpivaara, O., Mullally, A., Soares, M.B., Ebert, B.L., Levine, R. & Licht, J.D. (2012) miR-433 is aberrantly expressed in myeloproliferative >neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia, 27, 344-352.
76. Lu, J., Guo, S., Ebert, B.L., Zhang, H., Peng, X., Bosco, J., Pretz, J., Schlanger, R., Wang, J.Y., Mak, R.H., Dombkowski, D.M., Preffer, F.I., Scadden, D.T. & Golub, T.R. (2008) MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Developmental Cell, 14, 843-853.
77. Lu, L.F., Thai, T.H., Calado, D.P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G.B., Lee, H., Yoshimura, A., Rajewsky, K. & Rudensky, A.Y. (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity, 30, 80-91.
78. Lu, L.F., Boldin, M.P., Chaudhry, A., Lin, L.L., Taganov, K.D., Hanada, T., Yoshimura, A., Baltimore, D. & Rudensky, A.Y. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell, 142, 914-929.
79. Luciano, D.J., Mirsky, H., Vendetti, N.J. & Maas, S. (2004) RNA editing of a miRNA precursor. RNA, 10, 1174-1177.
80. Mendell, J.T. & Olson, E.N. (2012) MicroRNAs in stress signaling and human disease. Cell, 148, 1172-1187.
81. Moliterno, A.R., Williams, D.M., Rogers, O., Isaacs, M.A. & Spivak, J.L. (2008) Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens. Experimental Hematology, 36, 1480-1486.
82. Monticelli, S., Ansel, K.M., Xiao, C., Socci, N.D., Krichevsky, A.M., Thai, T.H., Rajewsky, N., Marks, D.S., Sander, C., Rajewsky, K., Rao, A. & Kosik, K.S. (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biology, 6, R71.
83. Mullally, A., Lane, S.W., Ball, B., Megerdichian, C., Okabe, R., Al-Shahrour, F., Paktinat, M., Haydu, J.E., Housman, E., Lord, A.M., Wernig, G., Kharas, M.G., Mercher, T., Kutok, J.L., Gilliland, D.G. & Ebert, B.L. (2010) Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell, 17, 584-596.
84. Mullally, A., Poveromo, L., Schneider, R.K., Al-Shahrour, F., Lane, S.W. & Ebert, B.L. (2012) Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera. Blood, 120, 166-172.
85. Navarro, F., Gutman, D., Meire, E., Caceres, M., Rigoutsos, I., Bentwich, Z. & Lieberman, J. (2009) miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood, 114, 2181-2192.
86. Obad, S., dos Santos, C.O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E.M., Hansen, H.F., Koch, T., Pappin, D., Hannon, G.J. & Kauppinen, S. (2011) Silencing of microRNA families by seed-targeting tiny LNAs. Nature Genetics, 43, 371-378.
87. O'Connell, R.M. & Baltimore, D. (2012) MicroRNAs and hematopoietic cell development. Current Topics in Developmental Biology, 99, 145-174.
88. O'Connell, R.M., Rao, D.S., Chaudhuri, A.A., Boldin, M.P., Taganov, K.D., Nicoll, J., Paquette, R.L. & Baltimore, D. (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. Journal of Experimental Medicine, 205, 585-594.
89. O'Connell, R.M., Chaudhuri, A.A., Rao, D.S., Gibson, W.S., Balazs, A.B. & Baltimore, D. (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proceedings of the National Academy of Sciences of the USA, 107, 14235-14240.
90. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. & Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
91. Ooi, A.G., Sahoo, D., Adorno, M., Wang, Y., Weissman, I.L. & Park, C.Y. (2010) MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proceedings of the National Academy of Sciences of the USA, 107, 21505-21510.
92. Pase, L., Layton, J.E., Kloosterman, W.P., Carradice, D., Waterhouse, P.M. & Lieschke, G.J. (2009) miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2. Blood, 113, 1794-1804.
93. Pelosi, E., Labbaye, C. & Testa, U. (2009) MicroRNAs in normal and malignant myelopoiesis. Leukemia Research, 33, 1584-1593.
94. Popovic, R., Riesbeck, L.E., Velu, C.S., Chaubey, A., Zhang, J., Achille, N.J., Erfurth, F.E., Eaton, K., Lu, J., Grimes, H.L., Chen, J., Rowley, J.D. & Zeleznik-Le, N.J. (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood, 113, 3314-3322.
95. Pramanik, D., Campbell, N.R., Karikari, C., Chivukula, R., Kent, O.A., Mendell, J.T. & Maitra, A. (2011) Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Molecular Cancer Therapeutics, 10, 1470-1480.
96. Rao, D.S., O'Connell, R.M., Chaudhuri, A.A., Garcia-Flores, Y., Geiger, T.L. & Baltimore, D. (2010) MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity, 33, 48-59.
97. Rasmussen, K.D., Simmini, S., Abreu-Goodger, C., Bartonicek, N., Di Giacomo, M., Bilbao-Cortes, D., Horos, R., Von Lindern, M., Enright, A.J. & O'Carroll, D. (2010) The miR-144/451 locus is required for erythroid homeostasis. Journal of Experimental Medicine, 207, 1351-1358.
98. Rodriguez, A., Vigorito, E., Clare, S., Warren, M.V., Couttet, P., Soond, D.R., van Dongen, S., Grocock, R.J., Das, P.P., Miska, E.A., Vetrie, D., Okkenhaug, K., Enright, A.J., Dougan, G., Turner, M. & Bradley, A. (2007) Requirement of bic/microRNA-155 for normal immune function. Science, 316, 608-611.
99. Romania, P., Lulli, V., Pelosi, E., Biffoni, M., Peschle, C. & Marziali, G. (2008) MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. British Journal of Haematology, 143, 570-580.
100. Ruby, J.G., Jan, C.H. & Bartel, D.P. (2007) Intronic microRNA precursors that bypass Drosha processing. Nature, 448, 83-86.
101. Ruggeri, M., Tosetto, A., Frezzato, M. & Rodeghiero, F. (2003) The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis. Annals of Internal Medicine, 139, 470-475.
102. Scott, L.M., Scott, M.A., Campbell, P.J. & Green, A.R. (2006) Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood, 108, 2435-2437.
103. Selbach, M., Schwanhausser, B., Thierfelder, N., Fang, Z., Khanin, R. & Rajewsky, N. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature, 455, 58-63.
104. Shen, W.F., Hu, Y.L., Uttarwar, L., Passegue, E. & Largman, C. (2008) MicroRNA-126 regulates HOXA9 by binding to the homeobox. Molecular and Cellular Biology, 28, 4609-4619.
105. Shiohama, A., Sasaki, T., Noda, S., Minoshima, S. & Shimizu, N. (2003) Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochemical and Biophysical Research Communications, 304, 184-190.
106. Shirdel, E.A., Xie, W., Mak, T.W. & Jurisica, I. (2011) NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS ONE, 6, e17429.
107. Slezak, S., Jin, P., Caruccio, L., Ren, J., Bennett, M., Zia, N., Adams, S., Wang, E., Ascensao, J., Schechter, G. & Stroncek, D. (2009) Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a. Journal of Translational Medicine, 7, 39.
108. Starczynowski, D.T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R.A., Buckstein, R., Lam, W., Humphries, R.K. & Karsan, A. (2010) Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nature Medicine, 16, 49-58.
109. Stefani, G. & Slack, F.J. (2008) Small non-coding RNAs in animal development. Nature Reviews Molecular Cell Biology, 9, 219-230.
110. Stein, B.L., Williams, D.M., Wang, N.Y., Rogers, O., Isaacs, M.A., Pemmaraju, N., Spivak, J.L. & Moliterno, A.R. (2010) Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders. Haematologica, 95, 1090-1097.
111. Stenvang, J., Silahtaroglu, A.N., Lindow, M., Elmen, J. & Kauppinen, S. (2008) The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Seminars in Cancer Biology, 18, 89-102.
112. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the USA, 103, 12481-12486.
113. Tefferi, A. (2012) JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood, 119, 2721-2730.
114. Tefferi, A., Vaidya, R., Caramazza, D., Finke, C., Lasho, T. & Pardanani, A. (2011) Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. Journal of Clinical Oncology, 29, 1356-1363.
115. Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J.L., Schmidt-Supprian, M., Rajewsky, N., Yancopoulos, G., Rao, A. & Rajewsky, K. (2007) Regulation of the germinal center response by microRNA-155. Science, 316, 604-608.
116. Theocharides, A., Boissinot, M., Girodon, F., Garand, R., Teo, S.S., Lippert, E., Talmant, P., Tichelli, A., Hermouet, S. & Skoda, R.C. (2007) Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood, 110, 375-379.
117. Trang, P., Wiggins, J.F., Daige, C.L., Cho, C., Omotola, M., Brown, D., Weidhaas, J.B., Bader, A.G. & Slack, F.J. (2011) Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Molecular Therapy, 19, 1116-1122.
118. Vaidya, R., Gangat, N., Jimma, T., Finke, C.M., Lasho, T.L., Pardanani, A. & Tefferi, A. (2012) Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. American Journal of Hematology, 87, 1003-1005.
119. Vasudevan, S., Tong, Y. & Steitz, J.A. (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-1934.
120. Velu, C.S., Baktula, A.M. & Grimes, H.L. (2009) Gfi1 regulates miR-21 and miR-196b to control myelopoiesis. Blood, 113, 4720-4728.
121. Ventura, A. & Jacks, T. (2009) MicroRNAs and cancer: short RNAs go a long way. Cell, 136, 586-591.
122. Verstovsek, S., Mesa, R.A., Gotlib, J., Levy, R.S., Gupta, V., DiPersio, J.F., Catalano, J.V., Deininger, M., Miller, C., Silver, R.T., Talpaz, M., Winton, E.F., Harvey, J.H. Jr, Arcasoy, M.O., Hexner, E., Lyons, R.M., Paquette, R., Raza, A., Vaddi, K., Erickson-Viitanen, S., Koumenis, I.L., Sun, W., Sandor, V. & Kantarjian, H.M. (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. New England Journal of Medicine, 366, 799-807.
123. Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X.L., Han, J.D. & Chen, Y.G. (2008) MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood, 111, 588-595.
124. Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R. & He, X. (2010) Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene, 29, 2302-2308.
125. Xiao, C., Calado, D.P., Galler, G., Thai, T.H., Patterson, H.C., Wang, J., Rajewsky, N., Bender, T.P. & Rajewsky, K. (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell, 131, 146-159.
126. Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L. & Rajewsky, K. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunology, 9, 405-414.
127. Yekta, S., Shih, I.H. & Bartel, D.P. (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594-596.
128. Yu, D., dos Santos, C.O., Zhao, G., Jiang, J., Amigo, J.D., Khandros, E., Dore, L.C., Yao, Y., D'Souza, J., Zhang, Z., Ghaffari, S., Choi, J., Friend, S., Tong, W., Orange, J.S., Paw, B.H. & Weiss, M.J. (2010) miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes & Development, 24, 1620-1633.
129. Zhan, H. & Spivak, J.L. (2009) The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era. Clinical Advances in Hematology and Oncology, 7, 334-342.
130. Zhan, M., Miller, C.P., Papayannopoulou, T., Stamatoyannopoulos, G. & Song, C.Z. (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Experimental Hematology, 35, 1015-1025.
131. Zhan, H., Cardozo, C., Yu, W., Wang, A., Moliterno, A.R., Dang, C.V. & Spivak, J.L. (2012) MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients. Blood Cells, Molecules, & Diseases, 50, 190-195.
132. Zhang, L., Sankaran, V.G. & Lodish, H.F. (2012) MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment. Leukemia, 26, 2310-2316.
133. Zhao, R., Xing, S., Li, Z., Fu, X., Li, Q., Krantz, S.B. & Zhao, Z.J. (2005) Identification of an acquired JAK2 mutation in polycythemia vera. Journal of Biological Chemistry, 280, 22788-22792.
134. Zhao, H., Kalota, A., Jin, S. & Gewirtz, A.M. (2009) The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood, 113, 505-516.
135. Zhao, J.L., Rao, D.S., Boldin, M.P., Taganov, K.D., O'Connell, R.M. & Baltimore, D. (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proceedings of the National Academy of Sciences of the USA, 108, 9184-9189.
136. Zhou, B., Wang, S., Mayr, C., Bartel, D.P. & Lodish, H.F. (2007) miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proceedings of the National Academy of Sciences of the USA, 104, 7080-7085.